From May 19 to 21, 2026, MedVallée will participate for the fourth consecutive year in the SantExpo trade show, alongside the Occitanie Region and the Montpellier University Innovation Hub (PUI).
Located in Hall 1 – Booth F42, MedVallée will be part of an event that every year brings together all the key players involved in the healthcare system’s ongoing transformation: established companies, startups, laboratories, healthcare facilities, researchers, investors, associations, and public decision-makers.
An ecosystem dedicated to innovation in healthcare
Throughout the event, MedVallée and its partners will highlight:
- Innovations from laboratories and deep-tech startups
- High-impact projects in the fields of prevention, diagnostics, biotechnology, digital health, and environmental health
- Opportunities for collaboration between research, businesses, and institutions
Aligned with SantExpo’s theme for 2026 – “Excellence in Health: A Commitment for All Generations” – the Montpellier delegation will showcase how the area is contributing to major priorities: innovation, ecological transformation, AI in healthcare, autonomy, women’s health, mental health, and quality of care.
Join the MedVallée - Montpellier PUI roundtable on May 20 at 4:00 PM
Roundtable title: “Montpellier, territory of excellence in One Health research and innovation!”
Featuring:
- Anne Ferrer - General Director of the Montpellier CHU University Hospital
- Christian Assaf - Vice President of Montpellier Méditerranée Métropole, Delegate for Economic Development and Attractiveness
- Magali Roubieu, Director of the Department of Strategic Programs at the University of Montpellier
- Ian Soulairol, Director of Technology, MB-Therapeutics
- Moderation by Daniel Laune, CEO of KYomed INNOV
Participating companies
- CAREPROD – May 19, morning
CAREPROD is an audiovisual and event production company specializing in the creation of high-impact video content in France and internationally. Partnering with agencies, event organizers, and public and private sector stakeholders, the company designs high-end formats that showcase expertise, services, and innovations. With a long-standing presence in the medical sector, CAREPROD is involved in educational, institutional, and promotional projects.
- Famille Santé – May 19, afternoon
Famille Santé is a family health app that provides access to pediatric first aid. It allows families to quickly obtain an initial medical opinion and be directed to the appropriate level of care, particularly in areas with limited resources. Deployed in Occitanie, the solution is designed to improve access to care, streamline pediatric care pathways, and reduce unnecessary visits to the emergency room.
- MB Therapeutics – May 20, morning
MB Therapeutics has developed an innovative solution for 3D printing of personalized medications in pharmacies. Its turnkey technology enables dosages to be precisely tailored to patients’ individual requirements, particularly in pediatrics and geriatrics. Already tested in several healthcare facilities, the company hopes to roll out the solution across Europe by 2027.
- INSEPARABLE – May 20, afternoon
INSEPARABLE is a digital solution that maintains the connection between critically ill patients, their loved ones, and caregivers, even in situations involving isolation. By structuring and securing communication, it improves the experience for families while supporting medical teams. Tested at Montpellier CHU University Hospital, the solution is scheduled for multi-site deployment starting in 2026.
- REGEnLIFE – May 21, morning
REGEnLIFE has developed a non-invasive neuromodulation solution for use in the treatment of neurological disorders, with an initial focus on Alzheimer’s disease. Based on innovative photonic technology, it is designed to be as effective as existing treatments, with fewer side effects and the ability to be used at home. The goal of the solution is to improve patients’ quality of life over the long term.
- ALCEDIAG – May 21, afternoon
ALCEDIAG develops innovative diagnostic tests in psychiatry, including the EDIT-B test, designed to improve management of bipolar disorders. Available in France since 2024, the test has received strong scientific and institutional recognition, as well as support from national and European clinical collaborations. Clinical utility studies are underway to support its coverage by the national health insurance system.
Through its presence at SantExpo 2026, MedVallée Montpellier once again asserts its role as a global hub for excellence in One Health, where academic research, technological innovation, industry, support structures, and public stakeholders all work together.
